Norman Koglin

5.9k total citations
59 papers, 1.4k citations indexed

About

Norman Koglin is a scholar working on Radiology, Nuclear Medicine and Imaging, Cancer Research and Physiology. According to data from OpenAlex, Norman Koglin has authored 59 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Radiology, Nuclear Medicine and Imaging, 16 papers in Cancer Research and 10 papers in Physiology. Recurrent topics in Norman Koglin's work include Medical Imaging Techniques and Applications (28 papers), Cancer, Hypoxia, and Metabolism (16 papers) and Radiopharmaceutical Chemistry and Applications (10 papers). Norman Koglin is often cited by papers focused on Medical Imaging Techniques and Applications (28 papers), Cancer, Hypoxia, and Metabolism (16 papers) and Radiopharmaceutical Chemistry and Applications (10 papers). Norman Koglin collaborates with scholars based in Germany, United States and South Korea. Norman Koglin's co-authors include Andrew Stephens, André Mueller, Santiago Bullich, Ludger M. Dinkelborg, Mathias Berndt, Susan De Santi, Aleksandar Jovalekic, Annette G. Beck‐Sickinger, John Seibyl and Ana M. Catafau and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and PLoS ONE.

In The Last Decade

Norman Koglin

58 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Norman Koglin Germany	22	536	367	308	289	259	59	1.4k
Jun Toyohara Japan	25	796 1.5×	747 2.0×	206 0.7×	121 0.4×	149 0.6×	144	2.2k
Shintaro Nishimura Japan	23	321 0.6×	599 1.6×	244 0.8×	81 0.3×	127 0.5×	76	1.5k
Tomoteru Yamasaki Japan	27	592 1.1×	809 2.2×	267 0.9×	92 0.3×	138 0.5×	117	2.1k
Katsushi Kumata Japan	25	586 1.1×	748 2.0×	369 1.2×	102 0.4×	126 0.5×	115	2.0k
Akiko Hatori Japan	27	607 1.1×	754 2.1×	242 0.8×	93 0.3×	129 0.5×	106	2.0k
K. Hamacher Germany	16	1.2k 2.3×	336 0.9×	118 0.4×	308 1.1×	112 0.4×	33	2.1k
Joji Yui Japan	26	500 0.9×	609 1.7×	208 0.7×	75 0.3×	123 0.5×	82	1.7k
Dirk Bender Denmark	27	572 1.1×	382 1.0×	164 0.5×	111 0.4×	77 0.3×	81	1.8k
Qi-Huang Zheng United States	26	484 0.9×	681 1.9×	110 0.4×	236 0.8×	130 0.5×	93	1.9k
Peter Johnström Sweden	24	1.2k 2.2×	620 1.7×	480 1.6×	241 0.8×	183 0.7×	74	3.4k

Countries citing papers authored by Norman Koglin

Since Specialization

Citations

This map shows the geographic impact of Norman Koglin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norman Koglin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norman Koglin more than expected).

Fields of papers citing papers by Norman Koglin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norman Koglin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norman Koglin. The network helps show where Norman Koglin may publish in the future.

Co-authorship network of co-authors of Norman Koglin

This figure shows the co-authorship network connecting the top 25 collaborators of Norman Koglin. A scholar is included among the top collaborators of Norman Koglin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norman Koglin. Norman Koglin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sotolongo‐Grau, Óscar, Núria Roé-Vellvé, Juan Pablo Tartari, et al.. (2025). Quantification of baseline amyloid PET in individuals with subjective cognitive decline can identify risk of amyloid accumulation and cognitive worsening: the FACEHBI study. European Journal of Nuclear Medicine and Molecular Imaging. 52(10). 3578–3590. 1 indexed citations

Bollack, Ariane, Lyduine E. Collij, Mahnaz Shekari, et al.. (2024). The Centiloid scale: guidance on clinical context of use from the AMYPAD Consortium. Alzheimer s & Dementia. 20(S2). 1 indexed citations

Jovalekic, Aleksandar, Santiago Bullich, Núria Roé-Vellvé, et al.. (2024). Experiences from Clinical Research and Routine Use of Florbetaben Amyloid PET—A Decade of Post-Authorization Insights. Pharmaceuticals. 17(12). 1648–1648. 1 indexed citations

Collij, Lyduine E., Ariane Bollack, Renaud La Joie, et al.. (2024). Centiloid recommendations for clinical context‐of‐use from the AMYPAD consortium. Alzheimer s & Dementia. 20(12). 9037–9048. 22 indexed citations

Koglin, Norman, et al.. (2024). Clinical [18F]FSPG Positron Emission Tomography Imaging Reveals Heterogeneity in Tumor-Associated System xc− Activity. Cancers. 16(7). 1437–1437. 6 indexed citations

Jovalekic, Aleksandar, Núria Roé-Vellvé, Norman Koglin, et al.. (2023). Validation of quantitative assessment of florbetaben PET scans as an adjunct to the visual assessment across 15 software methods. European Journal of Nuclear Medicine and Molecular Imaging. 50(11). 3276–3289. 21 indexed citations

Aghakhanyan, Gayanè, Michael Rullmann, Jost‐Julian Rumpf, et al.. (2022). Interplay of tau and functional network connectivity in progressive supranuclear palsy: a [18F]PI-2620 PET/MRI study. European Journal of Nuclear Medicine and Molecular Imaging. 50(1). 103–114. 8 indexed citations

Seo, Minjung, Yeji Kim, Byong Duk Ye, et al.. (2022). PET Imaging of System x_C⁻ in Immune Cells for Assessment of Disease Activity in Mice and Patients with Inflammatory Bowel Disease. Journal of Nuclear Medicine. 63(10). 1586–1591. 6 indexed citations

Bullich, Santiago, André Mueller, Susan De Santi, et al.. (2022). Evaluation of tau deposition using 18F-PI-2620 PET in MCI and early AD subjects—a MissionAD tau sub-study. Alzheimer s Research & Therapy. 14(1). 105–105. 16 indexed citations

10.

Roeber, Sigrun, Anja K. E. Horn, Thomas Arzberger, et al.. (2021). Superiority of Formalin-Fixed Paraffin-Embedded Brain Tissue for in vitro Assessment of Progressive Supranuclear Palsy Tau Pathology With [18F]PI-2620. Frontiers in Neurology. 12. 684523–684523. 9 indexed citations

11.

Mosci, Camila, Mirwais Wardak, Norman Koglin, et al.. (2020). Initial evaluation of (4S)-4-(3-[18F]fluoropropyl)-l-glutamate (FSPG) PET/CT imaging in patients with head and neck cancer, colorectal cancer, or non-Hodgkin lymphoma. EJNMMI Research. 10(1). 100–100. 16 indexed citations

12.

Greenwood, Hannah E., Patrick N. McCormick, Thibault Gendron, et al.. (2019). Measurement of Tumor Antioxidant Capacity and Prediction of Chemotherapy Resistance in Preclinical Models of Ovarian Cancer by Positron Emission Tomography. Clinical Cancer Research. 25(8). 2471–2482. 33 indexed citations

13.

Chae, Sun Young, Tae‐Won Kwon, Sun U. Kwon, et al.. (2019). A phase 1, first-in-human study of 18F-GP1 positron emission tomography for imaging acute arterial thrombosis. EJNMMI Research. 9(1). 28 indexed citations

14.

Beinat, Corinne, Gayatri Gowrishankar, Bin Shen, et al.. (2019). The Characterization of ¹⁸F-hGTS13 for Molecular Imaging of x_C⁻ Transporter Activity with PET. Journal of Nuclear Medicine. 60(12). 1812–1817. 11 indexed citations

15.

Mosci, Camila, Norman Koglin, Andrew Stephens, et al.. (2016). Characterization of Physiologic¹⁸F FSPG Uptake in Healthy Volunteers. Radiology. 279(3). 898–905. 13 indexed citations

16.

Schipke, Carola G., Norman Koglin, Santiago Bullich, et al.. (2016). Correlation of florbetaben PET imaging and the amyloid peptide Aß42 in cerebrospinal fluid. Psychiatry Research Neuroimaging. 265. 98–101. 9 indexed citations

17.

Kavanaugh, Gina M., Michael L. Nickels, Ronald C. Walker, et al.. (2016). Utility of [18F]FSPG PET to Image Hepatocellular Carcinoma: First Clinical Evaluation in a US Population. Molecular Imaging and Biology. 18(6). 924–934. 40 indexed citations

18.

Na, Sae Jung, Erik Mittra, Hanjong Ahn, et al.. (2013). Pilot clinical trial of (4S)-4-(3-[18F]fluoropropyl)-L-glutamate PET in patients with prostate cancer. 54(10). 285–285. 2 indexed citations

19.

Baek, Sora, Chang‐Min Choi, Sei Hyun Ahn, et al.. (2012). Exploratory Clinical Trial of (4 S )-4-(3-[18F]fluoropropyl)- l -glutamate for Imaging xC− Transporter Using Positron Emission Tomography in Patients with Non–Small Cell Lung or Breast Cancer. Clinical Cancer Research. 18(19). 5427–5437. 108 indexed citations

20.

Koglin, Norman, André Mueller, Mathias Berndt, et al.. (2011). Specific PET Imaging of xC− Transporter Activity Using a 18F-Labeled Glutamate Derivative Reveals a Dominant Pathway in Tumor Metabolism. Clinical Cancer Research. 17(18). 6000–6011. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact